Business News • PR NewsWire • NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London

NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London

NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London

LOS ANGELES, Feb. 11, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that Christopher DeGiorgio, M.D., Vice President of Neurology at NeuroSigma and Professor of Neurology at the University of California, Los Angeles (UCLA), and Colin...

View More : http://www.prnewswire.com/news-releases/neurosigma-invited-to-present-an-overview-of-etns-for-the-treatment-of-epilepsy-...

Releted News by prnewswire

Statement by the Honourable James Moore on the occasion of the 55th annual GRAMMY Awards

Creative Labels Purchases Epson SurePress for High Quality Digital Label Printing Across Wide Array of Applications

Dream-chasing at Anfi Resorts Gran Canaria

Research and Forecast of China's Coffee Cream Industry, 2013-2017

Kirby Corporation To Present At The BB&T Transportation Services Conference